Methicillin-resistant Staphylococcus aureus: Past, present, and - Too much of a - Future

Israel Medical Association Journal

Volumn 7, Issue 3, 2005, Pages 194-196

  Wiener Well, Yonit ^a,b   Yinnon, Amos M ^a,b  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Linezolid; Methicillin resistant Staphylococcus aureus; Methicillin susceptible S. aureus

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; FUSIDIC ACID; LINEZOLID; METICILLIN; OXAZOLIDINONE DERIVATIVE; PENICILLIN BINDING PROTEIN 2A; PENICILLIN G; RIFAMPICIN; TEICOPLANIN; TETRACYCLINE DERIVATIVE; TIGACYCLINE; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; DRUG EFFICACY; EDITORIAL; HAND WASHING; HOSPITAL INFECTION; HUMAN; IN VITRO STUDY; INFECTION PREVENTION; MEDICAL DECISION MAKING; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MORBIDITY; MORTALITY; PATIENT CARE; PRACTICE GUIDELINE; PREVALENCE; STAPHYLOCOCCUS AUREUS; STRAIN DIFFERENCE;

FORECASTING; HUMANS; METHICILLIN RESISTANCE; STAPHYLOCOCCUS AUREUS;

EID: 15844390231     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (17)

1. Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998;339: 520-31.
2. Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997;40:135-6.
3. Centers for Disease Control and Prevention. Staphylococcus aureus resistant to vancomycin - United States, 2002. MMWR 200252:565-7
4. Salgado CD, Farr BM, Calfee DP. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis 2003;36:131-9.
5. Samad A, Banerjee D, Carbarns N, Ghosh S. Prevalence of methicillin-resistant Staphylacoccus aureus colonization in surgical patients, on admission to a Welsh hospital. J Hosp Infect 2002;51:43-6.
6. Schlesinger Y, Yahalom S, Raveh D, et al. Methicillin-resistant Staphylococcus aureus nasal colonization in children in Jerusalem: community vs. chronic care institutions. IMAJ 2003;5:847-51.
7. Carleton HA, Diep BA, Charlebois ED, Sensabaugh GF, Perdreau-Remington F. Community-adapted methicillin resistant Staphylococcus aureus (MRSA): population dynamics of an expanding community reservoir of MRSA. J Infect Dis 2004;190:1730-8.
8. Voss A, Milatovic D, Wallrauch-Schwarz C, Rosdahl VT, Braveny I. Methicillin-resistant Staphylococcus aureus in Europe. Eur J Clin Microbiol Infect Dis 1994:13:50-5.
9. Samra Z, Gadba R. Antibiotic susceptibility and phage typing of methicillin-resistant Staphylococcus aureus clinical isolates from blood cultures of 692 patients in 15 Israeli hospitals. Eur J Epidemiol 1993; 9:559-62.
10. Bishara J, Pitlik S, Samra Z, Levy I, Paul M, Leibovici L. Co-trimoxazole-sensitive, methicillin-resistant Staphylococcus aureus Israel, 1988-1977. Emerg Infect Dis 2003;9:1168-9.
11. Raveh D, Rudensky D, Schlesinger Y, Attias D, Yinnon AM. Trends in bacteremias: analysis of 7544 patient-specific bacteremic episodes spanning 11 years (1990-2000). J Hosp Infect 2003;55:196-203.
12. Mendelson G, Yearmack Y, Granot E, Ben-Israel J, Colodner R, Raz R. Staphylococcus aureus carrier state among elderly residents of a long-term care facility. J Am Med Dir Assoc 2003;4:125-7.
13. Engemann JJ, Carmeli Y, Cosgrove SE, et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 2003;36:592-8.
14. Stevens DL, Herr D, Lampiris H, Hunt JL, Batts DH, Hafkin B. Linezolid versus vancomycin for the treatment of methicillin resistant Staphylococcus aureus infections. Clin Infect Dis 2002;34:1481-90.
15. Samra Z, Ofer O, Shmuely H. Susceptibility of methicillin-resistant Staphylococcus aureas to vancomycin, teicoplanin, linezolid, pristinamycin and other antibiotics. IMAJ 2005;7:149-50.
16. Tsiodras S, Gold HS, Sakoulas G, et al. Linezolide resistance in a clinical isolate of Staphylococcus aureus. Lancet 2001;358:207-8.
17. Pittet D, Simon A, Hugonnet S, Pessoa-Silva CL, Sauvan V, Perneger TV. Hand hygiene among physicians: performance, beliefs. and perceptions. Ann Intern Med 2004;14:1-8.